Omrix Biopharmaceutical (OMRI)

Company Overview
Omrix Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the development and marketing of biological products for the biosurgical and passive immunotherapy markets. Its biosurgical product is a fibrin sealant used for hemostasis in surgical procedures and is marketed as Crosseal in the United States and as Quixil outside of the United States. The company’s passive immunotherapy products include Intravenous immunoglobulin, a product primarily used to provide ongoing treatment for primary immune deficiencies by providing a selection of antibodies that mimic a healthy immune system; Vaccinia immunoglobulin (VIG), a product designed to treat smallpox vaccine-related comp...
read more

QUOTE

As of 09:55AM EDT August 01, 2014
$ N/A   N/A (N/A%)
Today's Open: N/A Previous Close: N/A
Today's High: N/A Volume: N/A
Today's Low: N/A Avg Vol: N/A
52 Week High: N/A Bid (size): N/A
52 Week Low: N/A Ask (size): N/A

COMPANY INFO

To see the headquarters in Google Street View &trade, drag this yellow guy: over to the red pointer:

Contact Information:

Business Address: 630 FIFTH AVENUE, 22ND FLOOR NEW YORK NY 10111 (212) 887-6500
Mailing Address: 630 FIFTH AVENUE, 22ND FLOOR NEW YORK NY 10111
Phone: 212-887-6500
Fax: 212-887-6550
Website: http://www.omrix.com

Company Details:

Symbol: OMRI
SIC: 1349426
State location: NY
Sector: -
State of Inc: DE
Employees: 212
Type: NASDAQ

Key executives:

Name Age Position

LATEST ARTICLES

LATEST STOCK PROMOTIONS

Omrix Biopharmaceutical (OMRI) MESSAGE BOARD

Post # Subject Re Name Date
1 This stock has changed to $18.73. What was... 0
2 Here on this message board we are inviting... 0